CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

RECRUITING

Virginia Commonwealth University, Richmond

RECRUITING

Duke University Health System (DUHS), Durham

RECRUITING

Levine Cancer Institute, Charlotte

RECRUITING

Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics, Miami

RECRUITING

University of Alabama at Birmingham, Birmingham

RECRUITING

Tennessee Oncology, Nashville

RECRUITING

University of Kentucky/ Markey Cancer Center, Lexington

RECRUITING

Cleveland Clinic, Cleveland

RECRUITING

Oncology Hematology Care, Inc, Cincinnati

RECRUITING

Froedtert and the Medical College of Wisconsin, Milwaukee

RECRUITING

University of Texas Southwestern Medical Center, Dallas

RECRUITING

CU Anschutz Medical Campus, Anshutz Cancer Pavillion, Aurora

RECRUITING

Huntsman Cancer Institute, University of Utah, Salt Lake City

RECRUITING

Hackensack Meridian John Theurer Cancer Center, Hackensack